Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis

European Respiratory Journal

Volumn 15, Issue 3, 2000, Pages 440-448

  Egermayer, P ^a,c   Peacock, A J ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b WESTERN INFIRMARY   (United Kingdom)

^c Canterbury Resp Research Group   (New Zealand)

Author keywords

Chronic thromboembolic; Pathophysiology; Pulmonary arteriopathy; Pulmonary atherosclerosis; Pulmonary embolism; Pulmonary hypertension

Indexed keywords

ARTERY OCCLUSION; DISEASE ASSOCIATION; ENDARTERECTOMY; HUMAN; LUNG EMBOLISM; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY ARTERY DISEASE; PULMONARY HYPERTENSION; REVIEW;

ANIMALS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; ENDARTERECTOMY; HUMANS; HYPERTENSION, PULMONARY; PULMONARY EMBOLISM; RECURRENCE; THROMBOEMBOLISM; THROMBOSIS;

EID: 0034059493     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.15.03.x     Document Type: Review

References (119)

1. Kanemoto N, Constant J. Present status of primary pulmonary hypertension. Tokai J Exp Clin Med 1989; 14: 257-280.
2. Editorial. Recurrent pulmonary embolism and cor pulmonale. N Engl J Med 1967; 276: 1261-1262.
3. Owen WR, Thomas WA, Castleman B, Bland EF. Unrecognised emboli to the lungs with subsequent cor pulmonale. N Engl J Med 1953; 249: 919-926.
4. Davidson PH, Armitage GH, McIlveen DJS. Chronic cor pulmonale due to silent pulmonary embolism. Lancet 1956; 2: 224-226.
5. Goodwin JF, Harrison CV, Wilcken DEL. Obliterative pulmonary hypertension and thrombo-embolism. BMJ 1963; 1: 701-711.
6. Fedullo PF, Auger WR, Channick RN, Moser KM, Jamieson SW. Chronic thromboembolic pulmonary hypertension. Clin Chest Med 1995; 16: 353-374.
7. Widimsky J. The relation between acute embolism and thromboembolic pulmonary hypertension. Vnitrni Lekarstvi 1990; 36: 503-507.
8. Egermayer P, Town GI. The clinical significance of pulmonary embolism: uncertainties and implications for treatment - a debate. J Intern Med 1997; 241: 5-10.
9. Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 1990; 81: 1735-1743.
10. Wagenwoort CA. Primary pulmonary hypertension: pathology. In: Peacock AJ, ed. Pulmonary Circulation A Handbook for Clinicians, London, UK, Chapman & Hall Medical, 1996; pp. 325-338.
11. Harris P, Heath D. The human pulmonary circulation. Its form and function in health and disease. Edinburgh, UK, Churchill Livingstone, 1986; pp. 403-413.
12. Cool CD, Kennedy D, Voelkel NF, Tuder RM. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with sceleroderma and human immunodeficiency virus infection. Hum Pathol 1997; 28: 434-442.
13. Schnader J, Schloo BL, Anderson W, Stephenson LW, Fishman AP. Chronic pulmonary hypertension in sheep: temporal progression of lesions. J Surg Res 1996; 62: 243-250.
14. Fukuhara H, Kitayama H, Yokoyama T, Shirotani H. Thromboembolic pulmonary hypertension due to disseminated fibromuscular dysplasia. Ped Cardiol 1996; 17: 340-345.
15. Presbitero P, Chiotti D, Brusca A. Differences in patients with chronic pulmonary embolism and primary pulmonary hypertension. G Ital Cardiol 1988; 18: 39-49.
16. Whittaker W, Heath D. Idiopathic pulmonary hypertension: etiology, pathogenesis, diagnosis and treatment. Prog Cardiovasc Dis 1959; 1: 380-386.
17. Reid L, Anderson G, Simon G. Comparison of primary and thromboembolic pulmonary hypertension. Thorax 1972; 27: 263-264.
18. Wagenvoort CA. Morphological substrate for the reversibility and irreversibility of pulmonary hypertension. Eur Heart J 1988; 9 (Suppl. J): 7-12.
19. Wagenwoort CA, Mulder PGH. Thrombotic lesions in primary plexogenic arteriopathy. Similar pathogenesis or complication? Chest 1993; 103: 844-849.
20. Wagenvoort CA. Pathology of pulmonary thromboembolism. Chest 1995; 107: 10S-17S.
21. Viner SM, Bagg BR, Auger WG, Ford GT. The management of pulmonary hypertension secondary to chronic thromboembolic disease. Prog Cardiovasc Dis 1994; XXXVII: 79-92.
22. Sabiston DC, Durham NC, Wagner HN. The pathophysiology of pulmonary embolism: relationship to accurate diagnosis and choice of therapy. J Thorac Cardiovasc Surg 1965; 50: 339-356.
23. Hamilton WM, Nemir P. The humoral factor in pulmonary embolism. Arch Surg 1972; 105: 593-598.
24. Smith G, Smith AN. The role of serotonin in experimental pulmonary embolism. Surg Gynecol Obstet 1955; 101: 691-699.
25. Gurewich V, Cohen ML, Thomas DP. Humoral factors in massive pulmonary embolism: an experimental study. Am Heart J 1968; 76: 784-791.
26. Tow DE, Wagner HN. Recovery of pulmonary arterial blood flow in patients with pulmonary embolism. N Engl J Med 1969; 280: 1195-1199.
27. Seeker-Walker RH, Jackson JA, Goodwin J. Resolution of pulmonary embolism. BMJ 1970; 4: 135-139.
28. Fred HL, Axelrad MA, Lewis JM, Alexander JK. Rapid resolution of pulmonary thromboemboli in man. An angiographie study. JAMA 1966; 196: 1137-1139.
29. Wechsler BM, Karlson KE, Summers DN, Krasnow N, Garzon AA, Chait A. Pulmonary embolism: influence of cardiac hemodynamics and natural history on selection of patients for embolectomy and inferior cava ligation. Surgery 1969; 65: 182-190.
30. Nielsen HK, Husted SE, Krusel LR, Fasting H, Charles P, Hansen HH. Silent pulmonary embolism in patients with deep venous thrombosis. Incidence and fate in a randomised controlled trial of anticoagulation versus no anticoagulation. J Intern Med 1994; 235: 457-461.
31. Cullis JO, Chisholm M, Ackery DM. Unresolved pulmonary embolism: the role of fibrinolysis. Nucl Med Commun 1993; 14: 4-7.
32. Olman MA, Marsh JJ, Lang IM, Moser KM, Binder BR, Schleef RR. Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension. Circulation 1992; 86: 1241-1248.
33. Widimsky J. Acute pulmonary embolism and chronic thromboembolic pulmonary hypertension: is there a relationship? Eur Respir J 1991; 4: 137-140.
34. Widimsky J. Mechanisms in embolic pulmonary hypertension. In: Wagewoort CA, Desolin H, eds. Pulmonary circulation. Amsterdam, the Netherlands, Elsevier, 1989; pp. 75-86.
35. Hall RJ, Sutton GC, Kerr IH. Long term prognosis of treated acute massive pulmonary embolism. Br Heart J 1977; 39: 1128-1134.
36. Benotti JR, Ockene IS, Alpert JS, Dalen JE. The clinical profile of unresolved pulmonary embolism. Chest 1983; 84: 669-677.
37. De Soyza NDB, Murphy ML. Persistant post-embolic pulmonary hypertension. Chest 1972; 62: 665-668.
38. Riedel M, Stanek V, Widimsky J. Long term follow-up of patients with pulmonary thromboembolism. Chest 1982; 81: 151-158.
39. Sharma GVRK, McIntyre KM, Sharma S, Sasahara AA. Clinical and hemodynamic correlates in pulmonary embolism. Clin Chest Med 1984; 5: 421-437.
40. Remy-Jardin M, Louvegny S, Remy J, et al. Acute central thromboembolic disease: posttherapeutic follow-up with spiral CT angiography. Radiology 1997; 203: 173-180.
41. Schuck JW, Walder JS, Kam TH, Thomas HM. Chronic persistent pulmonary embolism. Report of three cases. Am J Med 1980; 69: 790-794.
42. LaRue MJ, Muraugh RJ. Pulmonary thromboembolism in dogs: 47 cases (1986-1987). J Am Vet Med Assoc 1990; 197: 1368-1372.
43. Marshall R, Sabiston DC, Allison PR, et al. Immediate and late effects of pulmonary embolism by large thrombi in dogs. Thorax 1963; 18: 1-9.
44. Treolata SO, Johnson MS, Schwauwecker DS. Like cats and dogs: no perfect animal model for thrombolysis. Radiology 1997; 202: 31-32.
45. Moser KM, Cantor JP, Olman M, et al. Chronic pulmonary thromboembolism in dogs treated with tranexamic acid. Circulation 1991; 83: 1371-1379.
46. Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 1990; 81: 1735-1743.
47. Falicov RE, Resnekov L, Petasnick J. Progressive pulmonary vascular obstruction and cor pulmonale due to repeated embolism from axillary vein thrombosis. Ann Intern Med 1970; 73: 429-431.
48. Garcin JM, Chanudet X, Brandstatt P, Dechaux JP, Clement R, Larroque P. Unusual complication of venous thrombosis of the upper limb. Revue de Pneumonologie Clinique 1993; 49: 147-152.
49. Ledesma CF, Campo Eschevarria JF, Zurbano GF, et al. Pulmonary hypertension secondary to multiple pulmonary thromboembolisms due to thrombosis of the right subclavian vein. Annales de Medicina Interna 1994; 11: 294-296.
50. Saviotti M. Chronic pulmonary hypertension caused by left axillary vein thrombosis. Report of a clinical case. Minerva Cardioangioligica 1994; 42: 191-194.
51. Quinson P, Lagable M, Mornex JF, Jegaden O, Thevenet F, Milon H. Phlebitis of the right upper limb and thromboembolic pulmonary hypertension. A propos of a case of heart-lung transplantation. Archives des Maladies du Coeur et des Vaisseaux 1994; 87: 287-290.
52. Gomes MR, Tamaso H, Nazarian GK, Bjarnason H, Dietz CA Jr, Hunter DW. Upper-extremity deep vein thrombosis and chronic pulmonary embolism resulting in pulmonary artery hypertension. AJR 1998; 170: 1532-1534.
53. Nelson JR, Smith JR. The pathologic physiology of pulmonary embolism. A physiologic discussion of the vascular reactions following pulmonary arterial obstruction by emboli of varying siz. Am Heart J 1959; 58: 916-933.
54. Steinberg B, Mundy CS. Experimental pulmonary embolism and infarction. Arch Pathol 1936; 22: 529.
55. Downing SE, Vidone RA. Pulmonary vascular responses to embolization with autologous thrombi. Surg Gynecol Obstet 1967; 269-278.
56. Olman MA, Gan RZ, Yen RT, et al. Effect of chronic thromboembolism on the pulmonary artery pressure-flow relationship in dogs. J Appl Physiol 1994; 76: 875-881.
57. Butterworth AE, Thorne KJI. Eosinophils and parisitic diseases. In: Smith H, Cook RM, eds. The handbook of immunopharmacology. Immunopharmacology of eosinophils. London, UK, Academic Press Harcount Brace Jovanovich, 1994; pp. 119-150.
58. Radow SK, Nachamkin I, Morrow C, et al. Foreign body granulomatosis. Clinical and immunologic findings. Am Rev Respir Dis 1983; 127: 575-580.
59. Winterbauer RH, Efenbein IB, Ball WC. Incidence and clinical significance of tumor embolization to the lungs. Am J Med 1968; 45: 271-290.
60. Veinot JP, Ford SE, Price RG. Subacute cor pulmonale due to tumor embolization. Arch Pathol Lab Med 1992; 116: 131-134.
61. Beech DJ, Putnam JB, Pollock RE. Treatment of the patient with lung metastases. Curr Prob Surg 1996; 33: 910-913.
62. Akiba Y, Nakano H, Osanai S, Matsumoto H, Kikuchi K. Role of nitric oxide in vasoreactivity caused by experimental pulmonary microembolism. Nippon Kyobu Geka Gakkai Zasshi 1995, 33: 1408-1414.
63. Rich S, Levitsky S, Brundage BH. Pulmonary hypertension from chronic pulmonary thromboembolism. Ann Intern Med 1988; 108: 425-434.
64. Neumann RD, Sostman HD. Gottschalk A. Current status of ventilation-perfusion imaging. Semin Nucl Med 1980; X: 198-237.
65. Abraham P, Carter D, Millot JR, Leftheriotis G, Pidhorz L, Saumet JL. Prolonged asymptomatic micro-embolism after hip or knee arthroplasty. J Bone Joint Surg Br 1997; 79: 269-272.
66. Olsen EGF. Repeated pulmonary thromboembolism in rabbits. Lab Invest 1975; 32: 323-329.
67. Schneider J, Seidl I, Weihe WH, Hess OM, Krayenbuhl HP. Massive pulmonary embolism in dogs without pulmonary hypertension. Res Exp Med 1980; 177: 43-52.
68. Sato K, Webb S, Tucker A, et al. Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat. Am Rev Respir Dis 1992; 145: 793-797.
69. Fedde MR, Widemari RF Jr. Blood viscosity in broilers: influence on pulmonary hypertension syndrome. Poult Sci 1996; 75: 1261-1267.
70. Enkvetchakul B, Beasley HJ, Bottje W. Pulmonary arteriole hypertrophy in broilers with pulmonary hypertension syndrome (ascites). Poult Sci 1995; 74: 1677-1682.
71. Pringel JK, Bright JM, Duncan RB Jr, Kerr L, Linnarbary RD, Tarruer MP. Pulmonary hypertension in a group of dairy calves. J Am Vet Med Assoc 1991; 198: 857-861.
72. Bisgard GE. Pulmonary hypertension in cattle. Adv Vet Sci Comp Med 1977; 21: 151-172.
73. Berg R, Pehlemann K. Anatomic studies of the pulmonary hypertension syndrome in the domestic pig. Anat Histol Embryol 1987; 16: 265-270.
74. Gelberg HB, Smetzer DL, Forman JH. Pulmonary hypertension as a cause of atrial fibrillation in young horses: four cases (1980-1989). J Am Vet Med Assoc 1991; 198: 679-682.
75. Egermayer P, Town GI, Peacock AJ. The role of serotonin in the pathophysiology of acute and chronic pulmonary hypertension. Thorax 1999; 54: 161-168.
76. Fadel E, Riou JY, Mazamanian M, et al. Pulmonary thromboendarterectomy for chronic thromboembolic obstruction of the pulmonary artery in piglets. J Thorac Cardiovasc Surg 1999; 117: 787-793.
77. Lang IM, Klepetko W, Pabinger I. No increased prevalence of Factor V Leiden mutation in chronic major vessel thromboembolic hypertension (CTEPH). Thromb Haemost 1996; 76: 476-477.
78. Auger WR, Permpikul P, Moser KM. Lupus anticoagulant, heparin use, and thrombocytopenia in patients with chronic thromboembolic hypertension: a preliminary report. Am J Med 1995; 99: 392-396.
79. Azarian R, Brenot F, Sitbon O, et al. Pulmonary arterial hypertension of chronic thrombo-embolic origin, 70 patients. Presse Med 1994; 23: 1017-1022.
80. De Clerck LS, Michielson PP, Ramael MR, et al. Portal and pulmonary vessel thrombosis associated with systemic lupus erythematosus and anticardiolipin antibodies. J Rheumatol 1991; 18: 1919-1921.
81. Marz W, Trommlitz M, Scharrer I, Gross W. Apolipoprotein (a) concentrations are not related to the risk of venous thrombosis. Blood Coagul Fibrinolysis 1991; 2: 595-599.
82. Ignatescu M, Kostner K, Zorn G, et al. Plasma Lp(a) levels are increased in patients with chronic thromboembolic pulmonary hypertension. Thromb Haemostas 1998; 80: 231-232.
83. Schafer AI, Kroll MH. Non atheromatous arterial thrombosis. Annu Rev Med 1993; 44: 155-170.
84. Sompradeek S, Fedullo PF, Le DT. Congenital and acquired thrombophilias in patients with chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 1999; 159: A358.
85. Peacock AJ. Primary pulmonary hyptertension. Thorax 1999; 54: 1107-1118.
86. Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 1993; 103: 685-692.
87. Egermayer P. Follow-up for death or recurrence is not a reliable way of assessing the accuracy of diagnostic tests for thromboembolic disease. Chest 1997; 111: 1410-1413.
88. Henry JW, Relyea B, Stein PD. Continuing risk of thromboemboli among patients with normal pulmonary angiograms. Chest 1995; 107: 1375-1378.
89. Bergqvist D. The role of vena caval interruption in patients with venous thromboembolism. Prog Cardiovasc Dis 1994; XXXVII: 25-37.
90. Ballew KA, Philbrick JT, Becker DM. Vena caval filter devices. Clin Chest Med 1995; 16: 295-305.
91. Michel RP, Hu F, Meyrick BO. Myoendothelial junctional complexes in postobstructive pulmonary vasculopathy: a quantitative electron microscope study. Experim Lung Res 1995; 21: 437-452.
92. Hirsch AM, Moser KM, Auger WR, Channick RN, Fedullo PF. Unilateral pulmonary artery thrombotic occlusion. Is distal arteriopathy a consequence? Am Rev Respir Crit Care Med 1996; 154: 491-496.
93. Shure D. Thrombendartectomy: some unanswered questions. Ann Thorac Surg 1996; 62: 1253-1254.
94. Weis M, von Scheidt W. Cardiac allograft vasculopathy. A review. Circulation 1997; 96: 2069-2077.
95. Sevitt S, Walton KW. Atherosclerotic lesions from the reduction of pulmonary emboli. Atherosclerosis 1986; 59: 173-185.
96. Uchida Y, Oshima T, Hirose J, Sasaki T, Morizuki S, Morita T. Angioscopic detection of residual pulmonary thrombi in the differential diagnosis of pulmonary embolism. Am Heart J 1995; 130: 854-859.
97. Kodama I, Sugada Y, Shimizu T, Hoshi S. Proceedings: pulmonary hypertension associated with marked pulmonary arteriosclerosis and thrombus formation. Japn Circ J 1975; 39: 874.
98. Yamamoto M. Pathology of experimental pulmonary bone marrow embolism. II Postembolic pulmonary arteriosclerosis and pulmonary hypertension in rabbits receiving an intravenous infusion of allogeneic bone marrow. Acta Pathol Japn 1987; 37: 705-724.
99. Moore GW, Smith RRL, Hutchins GM. Pulmonary artery atherosclerosis. Correlation with systemic atherosclerosis and hypertensive pulmonary vascular disease. Arch Pathol Lab Med 1982; 106: 378-380.
100. Sofia M, Faraone S, Alifano M, et al. Endothelin abnormalities in patients with pulmonary embolism. Chest 1997; 111: 544-549.
101. Robin ED, Cross CE, Kroetz F, Totten RS, Bron K. Pulmonary hypertension and unilateral pleural constriction with speculation on pulmonary vasoconstrictive substance. Arch Intern Med 1966; 118: 391-400.
102. Ross R, Wight TN, Strandness E, Thiele B. Human atherosclerosis. 1 Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol 1984; 114: 79-93.
103. Jamieson SW. Pulmonary thrombendartectomy. Heart 1998; 79: 118-120.
104. Moser KM, Fedullor PF. Acute and chronic pulmonary thromboembolism. In: Peacock AJ, (ed) Pulmonary Circulation. A Handbook for Clinicians. London, UK, Chapman & Hall Medical, 1996; pp. 391-442.
105. Chouat A, Weitzenblum E, Higgenbottam T. The role of thrombosis in severe pulmonary hypertension. Eur Respir J 1996; 9: 356-363.
106. Calverly PMA, Howatson R, Flenley DC. Clinicopathological correlations in cor pulmonale. Thorax 1992; 47: 494-498.
107. Presti B, Berthrong M, Sherwin RM. Chronic thrombosis of major pulmonary arteries. Hum Pathol 1990; 21: 601-606.
108. Eisenberg PR, Lucore C, Kaufman L, Sobel BE, Jaffe AS, Rich S. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension. Circulation 1990; 82: 841-847.
109. Symbas PN, Jacobs WF, Schlant RC. Chronic pulmonary artery embolization or thrombosis. Am J Cardiol 1971; 28: 342-347.
110. Schulman LL, Grossman BA, Owen J. Platelet activation and fibrinopeptide formation in pulmonary hypertension. Chest 1993; 104: 1690-1693.
111. Moser KM, Fedullo PF, Finkbeiner DC. Do patients with primary pulmonary hypertension develop extensive central thrombi? Circulation 1995; 91: 741-745.
112. Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frye RL. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1984; 70: 580-587.
113. Moser KM, Olson LK, Schlussberg M, Daily PO, Dembitsky WP. Chronic thromboembolic occlusion in the adult can mimic pulmonary artery agenesis. Chest 1989; 95: 503-508.
114. Kerr KM, Auger WR, Fedullo PF. Large vessel pulmonary arteritis mimicking chronic thromboembolic disease. Am J Respir Crit Care Med 1995; 152: 367-373.
115. Samuels N, Berkman N, Milgalter E, Bar-Zine J, Amir G, Kramer MR. Pulmonary hypertension secondary to neurofibromatosis: intimai fibrosis versus thromboembolism. Thorax 1999; 54: 858-859.
116. Berry DF, Buccigrosst D, Peabody J, Peterson K, Moser KM. Pulmonary vascular occlusion and fibrosing mediastinitis. Chest 1986; 2: 296-301.
117. Datz FL. Ventilation-perfusion mismatch: Lung imaging. Semin Nucl Med 1980; X: 193.
118. Tardivon AA, Musset D, Maitre S, et al. Role of CT in chronic pulmonary embolism: comparison with pulmonary angiography. J Comput Assist Tomo 1993; 17: 345-351.
119. Frank H, Mlczoch J, Huber K, Shuster E, Gurtner HP, Kneussel M. The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension. Chest 1997; 112: 714-721.